Literature DB >> 33399246

Prognosis Varies by Intrinsic Tumor Subtype in Patients Treated with Ribociclib.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33399246      PMCID： PMC7869330          DOI： 10.1002/onco.13660

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  3 in total

1.  Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.

Authors:  Debu Tripathy; Seock-Ah Im; Marco Colleoni; Fabio Franke; Aditya Bardia; Nadia Harbeck; Sara A Hurvitz; Louis Chow; Joohyuk Sohn; Keun Seok Lee; Saul Campos-Gomez; Rafael Villanueva Vazquez; Kyung Hae Jung; K Govind Babu; Paul Wheatley-Price; Michelino De Laurentiis; Young-Hyuck Im; Sherko Kuemmel; Nagi El-Saghir; Mei-Ching Liu; Gary Carlson; Gareth Hughes; Ivan Diaz-Padilla; Caroline Germa; Samit Hirawat; Yen-Shen Lu
Journal:  Lancet Oncol       Date:  2018-05-24       Impact factor: 41.316

2.  Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.

Authors:  Dennis J Slamon; Patrick Neven; Stephen Chia; Peter A Fasching; Michelino De Laurentiis; Seock-Ah Im; Katarina Petrakova; Giulia Val Bianchi; Francisco J Esteva; Miguel Martín; Arnd Nusch; Gabe S Sonke; Luis De la Cruz-Merino; J Thaddeus Beck; Xavier Pivot; Gena Vidam; Yingbo Wang; Karen Rodriguez Lorenc; Michelle Miller; Tetiana Taran; Guy Jerusalem
Journal:  J Clin Oncol       Date:  2018-06-03       Impact factor: 44.544

3.  Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Authors:  Gabriel N Hortobagyi; Salomon M Stemmer; Howard A Burris; Yoon-Sim Yap; Gabe S Sonke; Shani Paluch-Shimon; Mario Campone; Kimberly L Blackwell; Fabrice André; Eric P Winer; Wolfgang Janni; Sunil Verma; Pierfranco Conte; Carlos L Arteaga; David A Cameron; Katarina Petrakova; Lowell L Hart; Cristian Villanueva; Arlene Chan; Erik Jakobsen; Arnd Nusch; Olga Burdaeva; Eva-Maria Grischke; Emilio Alba; Erik Wist; Norbert Marschner; Anne M Favret; Denise Yardley; Thomas Bachelot; Ling-Ming Tseng; Sibel Blau; Fengjuan Xuan; Farida Souami; Michelle Miller; Caroline Germa; Samit Hirawat; Joyce O'Shaughnessy
Journal:  N Engl J Med       Date:  2016-10-07       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.